PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.
暂无分享，去创建一个
R. Burger | E. Sausville | R. Coleman | R. Messmann | N. Gabrail | P. Konstantinopoulos | R. Naumann | R. Penson | L. Gilbert | C. Leamon | J. Symanowski | M. Teneriello | E. Nowara | S. Ghamande | E. Kutarska | W. Harb | S. Depasquale | D. Morgenstern | R. Gersh | C. Lovejoy | Robert A. Burger | E A Sausville | R. Wendel Naumann | R. L. Coleman | Stephen E. DePasquale | Panagiotis A. Konstantinopoulos | James T. Symanowski | Christopher P. Leamon | David E. Morgenstern